REXai raises €1.5 million to embed AI into any e-commerce platform

Tech company REXai aims to make AI available as a service for companies looking to fast-forward their ability to use data to help improve the customer journey and meet business needs.

Founded in 2016 by CEO Saeed Younesi, REXai’s system translates visitor and customer data into meaningful personalisation – allowing clients to offer customers a better online experience while achieving their business goals more efficiently. The self-learning systems are powered by AI and work in real-time on an individual visitor level across all channels. 

“With our team of 17 data-engineers, scientists and software developers, we created an AI-first solution that moves away from business-rules based tools, instead relying on the power of artificial intelligence to create a self-learning solution that delivers better results for both businesses and their visitors,” Younesi explains.

The platform can interpret behaviour in real-time to predict customer intent and provide personalisation on an individual level in milliseconds - even during the time it takes to load a page or open an email - all while taking set business goals into consideration from its business dashboard.

The company will use their latest funding round to expand their sales and marketing teams and make its technology available to a broader audience of marketing and commerce professionals. 

Nico.lab raises €3 million and prepares for an IPO in Australia

A collaboration between VU University Medical Center Amsterdam and health-tech venture builder NLC, Nico.lab developed its software StrokeViewer to speed up the diagnosis and treatment of strokes. Founded in 2015, the ground-breaking MedTech venture raised €3 million from Australian investors earlier this year and is now planning an IPO in the country in early 2019.

Using AI, the software analyses brain scans to recognise and accurately assess stroke indicators to help medical professionals diagnose and treat strokes. While traditional processes usually take hours, AI dramatically shortens the time taken to determine the treatment for stroke to just three minutes. 

StrokeViewer won a European grant of €0.5m and is set to start clinical trials in Australia and North America. The US debut of StrokeViewer will take place early next year as tech giants such as Intel, HP and Google have partnered with Nico.lab to help it enter the American market.

Merel Boers, Chief Research Officer at Nico.lab, said: “We are very pleased with the great interest in our product that combines the latest clinical research results with state-of-the-art AI technology. This movement shows that an impact can be made in healthcare.”

Convious raises €3.6 million funding to open new R&D centre

Innovative AI tech startup Convious uses AI to deliver a data-driven customised online booking and buying experience for visitors. Established in 2016, the company has recently raised €3.6 million in funding to open a research and development centre in Lithuania.

CEO Camiel Kraan believes more businesses will start using AI to offer dynamic pricing directly to customers instead of offering mass discounts, eliminating the dependence on intermediaries and affiliates while boosting sales.

“We have seen that dated marketing practices that use a generalist approach fail to create value in what we like to call “the new economy”, which is data-driven and consumer-led. Our first customers have seen an increase from 30 to 100% by switching to a dynamic process model,” adds Kraan.

The company aims to help the global leisure and hospitality industry increase their shopping cart sales via personalised pricing solutions delivered via an AI-driven platform.

Learn more about Amsterdam’s AI industry.